Ovarian cancer ascites factor, in isolated form
US5277917A · kind A · utility
6Cited by
0References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 2, 1993 |
| Grant date | Jan 11, 1994 |
| Priority date | — |
| Expiry date | Apr 2, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K35/13
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Herein described is an ovarian cancer activating factor that has been isolated from ovarian cancer ascites fluid. The factor may be utilized in its isolated form in a screening program aimed at identifying inhibitors of factor-mediated ovarian cancer activation, or as a growth supplement useful for culturing ovarian and other cancer cell lines.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.